Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5278317 | 0.93 | FFAR1 (0.46) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL6037941 | 0.93 | ALDH1A1 (0.49) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL5280811 | 0.90 | ALDH1A1 (0.48) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL6038022 | 0.90 | FFAR1 (0.46) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL6037982 | 0.90 | HDAC1 (0.50) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL5283923 | 0.89 | FFAR4 (0.45) | FFAR1FFAR4ALDH1A1POLBMAPK1 | |
| SCHEMBL6038148 | 0.88 | ALDH1A1 (0.53) | ALDH1A1POLBMAPK1SMN1; SMN2LMNA | |
| SCHEMBL5277245 | 0.87 | FFAR1 (0.53) | FFAR1FFAR4ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5279126 | 0.87 | FFAR1 (0.47) | FFAR1FFAR4ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL6038161 | 0.87 | FFAR1 (0.53) | FFAR1FFAR4ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1863804-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2007-12-12 | — | — | EP | claimed |
| US-20060264415-A1 | Inhibitors of histone deacetylase | METHYLGENE INC. | 2006-11-23 | — | — | US | claimed |
| WO-2006102760-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2006-10-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264415-A1 | Inhibitors of histone deacetylase | HDAC1, HDAC3, HDAC11 | FFAR1 3897/4885FFAR4 4291/4885ALDH1A1 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.